US Patent 6887466 Methods for selectively stimulating proliferation of T cells

US Patent 12133867 Universal anti-CD22 chimeric antigen receptor engineered immune cells

US Patent 12123021 Gene-regulating compositions and methods for improved immunotherapy

US Patent 12122829 Human alpha-folate receptor chimeric antigen receptor

US Patent 12121541 Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

US Patent 12109234 Anti-BCMA CAR T cell compositions

US Patent 12104172 Processes for generating TIL products enriched for tumor antigen-specific t-cells

US Patent 12091681 Ex vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapy

US Patent 12091682 Methods for making, compositions comprising, and methods of using rejuvenated T cells

US Patent 12090147 Combination therapy with 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide

US Patent 12084682 Gene-regulating compositions and methods for improved immunotherapy

US Patent 12084518 Trispecific binding proteins and methods of use

US Patent 12060585 Expression of novel cell tags

US Patent 12060419 CD79A chimeric antigen receptors

US Patent 12018080 Methods and compositions for treating cancer by targeting the CLEC2D-KLRB1 pathway

US Patent 12012612 Engineered immune cells with receptor signal strength modulated by a hinge

US Patent 12006369 BCMA chimeric antigen receptors

US Patent 11999773 Anti-BCMA chimeric antigen receptors